Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results


Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report fourth quarter and full-year 2023 financial results after the Nasdaq Global Market closes on Wednesday, Feb. 28, 2024. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its fourth quarter and full-year 2023 financial results and to provide a corporate update.

The event will be webcast live under the investor relations section of Sarepta's website at https://investorrelations.sarepta.com/events-presentations and following the event a replay will be archived there for one year. Interested parties participating by phone will need to register using this online form. After registering for dial-in details, all phone participants will receive an auto-generated e-mail containing a link to the dial-in number along with a personal PIN number to use to access the event by phone.

About Sarepta Therapeutics

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information

We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.


These press releases may also interest you

at 20:45
Industrias Unidas, S.A. de C.V. ("IUSA" or the "Company") has announced its audited results for the twelve months ended December 31 of 2023. Figures are audited and have been prepared in accordance with Mexican Financial Reporting Standards ("MFRS"),...

at 20:40
Cambridge-Lee Holdings, Inc, has announced its audited consolidated results for the fiscal year 2023. CAMBRIDGE-LEE HOLDINGS, INC. AND SUBSIDIARIES (A Wholly Owned Subsidiary of Tubo de Pasteje S.A. de C.V.)   CONSOLIDATED BALANCE...

at 20:35
Cencosud S.A. reported today its first-quarter results, with revenues of CLP $ 3,938,070 million, an increase of 12.4% compared to the same period of the previous year. Among business categories with solid performance, double-digit growth in online...

at 20:30
MAX Power Mining Corp. ("Max Power" or the "Company") announces a non-brokered private placement of up to 8,500,000 units (the "Units") of the Company at a price of C$0.195 per Unit (the "Offering Price") for gross proceeds to the Company of up to...

at 20:15
Black Diamond Group Limited ("Black Diamond", the "Company" or "we"), , a leading provider of space rental and workforce accommodation solutions, today announced its operating and financial results for the three months ended March 31, 2024 (the...

at 20:00
Faircourt Asset Management Inc., the Manager of Faircourt Gold Income Corp. (the "Company") announces today that Securityholders who tendered their Class A Shares for redemption on March 28, 2024 will be entitled to receive $2.8944 per Class A Share,...



News published on and distributed by: